CA2731449A1 - Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules - Google Patents

Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules Download PDF

Info

Publication number
CA2731449A1
CA2731449A1 CA2731449A CA2731449A CA2731449A1 CA 2731449 A1 CA2731449 A1 CA 2731449A1 CA 2731449 A CA2731449 A CA 2731449A CA 2731449 A CA2731449 A CA 2731449A CA 2731449 A1 CA2731449 A1 CA 2731449A1
Authority
CA
Canada
Prior art keywords
form according
oral form
polymer
nanoparticles
less
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA2731449A
Other languages
English (en)
French (fr)
Inventor
Remi Meyrueix
Rafael Jorda
Anne-Sophie Daviaud
Alain Constancis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Publication of CA2731449A1 publication Critical patent/CA2731449A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5169—Proteins, e.g. albumin, gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
CA2731449A 2008-07-28 2009-07-24 Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules Abandoned CA2731449A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0855179A FR2934161B1 (fr) 2008-07-28 2008-07-28 Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules.
FR0855179 2008-07-28
PCT/FR2009/051495 WO2010012940A2 (fr) 2008-07-28 2009-07-24 Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules

Publications (1)

Publication Number Publication Date
CA2731449A1 true CA2731449A1 (fr) 2010-02-04

Family

ID=40210723

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2731449A Abandoned CA2731449A1 (fr) 2008-07-28 2009-07-24 Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules

Country Status (6)

Country Link
EP (1) EP2317990A2 (de)
JP (1) JP2011529100A (de)
CN (1) CN102131500A (de)
CA (1) CA2731449A1 (de)
FR (1) FR2934161B1 (de)
WO (1) WO2010012940A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2940619B1 (fr) * 2008-12-31 2012-02-10 Flamel Technologies Sa Composition comprenant un actif de solubilite aqueuse faible ou moyenne
EP3334776A4 (de) * 2015-08-13 2019-03-27 The Johns Hopkins University Verfahren zur herstellung von polyelektrolytkomplexnanopartikeln
CN107648182B (zh) * 2016-07-26 2020-03-17 天津大学 超稳定纳米药物载体mPEG-PGlu(D)-VE(D)及制备方法及用途
US11491114B2 (en) * 2016-10-12 2022-11-08 Curioralrx, Llc Formulations for enteric delivery of therapeutic agents
CN111698980A (zh) * 2018-02-06 2020-09-22 3M创新有限公司 具有多孔或中空的芯和pH敏感性壳的微胶囊及其用途
CN109875978A (zh) * 2019-04-12 2019-06-14 常州大学 一种可用于药物缓释的聚丙烯酸-生育酚琥珀酸酯自组装载药体系的制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2891459B1 (fr) * 2005-09-30 2007-12-28 Flamel Technologies Sa Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
FR2904219B1 (fr) * 2006-07-28 2010-08-13 Flamel Tech Sa Microparticules a base de copolymere amphiphile et de principe(s) actif(s) a liberation modifiee et formulations pharmaceutiques en contenant

Also Published As

Publication number Publication date
CN102131500A (zh) 2011-07-20
WO2010012940A3 (fr) 2010-03-25
JP2011529100A (ja) 2011-12-01
EP2317990A2 (de) 2011-05-11
WO2010012940A2 (fr) 2010-02-04
FR2934161B1 (fr) 2010-09-17
FR2934161A1 (fr) 2010-01-29

Similar Documents

Publication Publication Date Title
CA2748713C (fr) Composition comprenant un actif de faible solubilite aqueuse
EP0385846B1 (de) 2-Propylvaleriansäure enthaltende Arzneizubereitung mit verzögerter Wirkstofffreigabe
EP2488161B1 (de) Missbrauchssichere, orale feste dosierungsform mit einem modifizierten spezifischen freisetzungsprofil
CA2743767C (fr) Nouvelle composition a base d'acide gamma-hydroxybutyrique
EP2435030B1 (de) Schwebende pharmazeutische zusammensetzungen mit kontrollierter freisetzung
US20100021549A1 (en) Microparticle oral form useful for the modified release of nanoparticles
FR2725623A1 (fr) Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
WO2003084518A2 (fr) Suspension orale de microcapsules de principes actifs
WO2000030618A1 (fr) Particules a base de polyaminoacide(s) et leurs procedes de fabrication
CA2683741A1 (fr) Acides polyglutamiques fonctionnalises par des groupements cationiques et des groupements hydrophobes et leurs applications, notamment therapeutiques
CA2731449A1 (fr) Forme orale microparticulaire utile pour la liberation modifiee de nanoparticules
CA2894647A1 (fr) Forme orale, comprenant des particules enrobees a liberation immediate d'au moins un compose actif et resistantes au broyage
CA2721232C (fr) Forme orale solide dotee d'un double profil de liberation comprenant des multiparticules
EP2605757A2 (de) Auf nalbuphin basierende formuluerungen und ihre verwendung
CA2596147A1 (fr) Copolyhydroxyalkylglutamines fonctionnalises par des groupements hydrophobes et leurs applications notamment therapeutiques
WO2008113901A2 (fr) Composition à libération prolongée de lévétiracetam et procédé de préparation.
CA2763541C (fr) Procede de preparation de particules creuses et leurs applications
EP1549298B1 (de) Sphäroide, deren herstellungsverfahren und sphäroidenhaltige arzneimittel
FR2952936A1 (fr) Polymere de type acrylique ou methacrylique comprenant des greffons alpha-tocopherol
WO2016005689A1 (fr) Utilisation d'un homopolymere amine pour l'encapsulation d'ingredients, procede de synthese d'un homopolymere d'aema, et procede d'encapsulation d'ingredients
FR2805269A1 (fr) Polymeres et matrices cationiques bioeliminables a degradation controlee

Legal Events

Date Code Title Description
FZDE Discontinued

Effective date: 20140724